CRESTOR is not approved to prevent cardiovascular morbidity and mortality. CRESTOR is contraindicated in patients with a known hypersensitivity to any component of this product, in patients with ...
Pfizer Inc's Lipitor and AstraZeneca's Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients, according to data from a clinical trial ...
Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain. In ...
AstraZeneca PLC's Crestor cholesterol drug wasn't significantly better than rival Pfizer Inc.'s Lipitor in reversing artery-clogging plaque in a clinical trial. The outcome could make Crestor a ...
ORLANDO, Florida (Reuters) - A fresh look at data from a landmark study showed that AstraZeneca's powerful cholesterol fighter Crestor dramatically cut deaths, heart attacks and strokes in women at ...
In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well.more Lipitor (atorvastatin) and Crestor (rosuvastatin) both ...
The widely used cholesterol-lowering drug Crestor has at least twice the incidence of side effects as other drugs in the statin family, although it should still be considered safe for long-term use, ...
AstraZeneca scored a 'yes' vote at yesterday's FDA advisory panel meeting. The agency's expert advisors recommended the company's cholesterol drug Crestor for broader use--much broader use. If the ...
Kyoto, Japan, Monday 29 September 2003. New data presented at the XIIIth International Symposium on Atherosclerosis (ISA) show AstraZeneca's highly effective statin CRESTOR (rosuvastatin) achieves ...
AstraZeneca is trying to invoke the Orphan Drug Act to protect its blockbuster, on the grounds it is approved to treat a rare pediatric condition. Updates with report of FDA approval for generic ...
SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- A new analysis from the JUPITER study presented today at the International Stroke Conference (ISC) in San Diego ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results